Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Rating) – Equities research analysts at William Blair issued their Q1 2024 earnings per share estimates for Pyxis Oncology in a note issued to investors on Thursday, May 11th. William Blair analyst A. Hsieh forecasts that the company will earn ($0.56) per share for the quarter. William Blair has […]